PRA Health Sciences appoints new director
Monday, October 19, 2015
PRA Health Sciences has appointed Linda Grais, M.D. to the board of directors. Grais also will serve on the audit committee.
Grais has been a member of the board of directors of Ocera Therapeutics since January 2008 and president and chief executive officer of Ocera Therapeutics since June 2012. Previously, Grais was a managing member at InterWest Partners, a venture capital firm. Grais also was a founder and executive vice president of SGX Pharmaceuticals, a drug discovery company focusing on new treatments for cancer.